CAREDX INC. DL-,001 WKN: A118WG ISIN: US14167L1035 Kürzel: CDNA Forum: Aktien Thema: Hauptdiskussion
22,37 EUR
+0,77 %+0,17
23. Nov, 10:45:40 Uhr,
Lang & Schwarz
Kommentare 95
Summer.76,
09.08.2023 6:04 Uhr
0
CareDx Reports Second Quarter 2023 Results
https://www.businesswire.com/news/home/20230808569298/en/CareDx-Reports-Second-Quarter-2023-Results
Summer.76,
26.01.2024 19:50 Uhr
0
https://seekingalpha.com/news/4059239-caredx-drops-after-jury-votes-in-favor-of-natera-in-patent-fight
trompetenkaefer,
27.01.2024 19:02 Uhr
0
Leider bekomme ich den Link nicht auf. Was ist der Inhalt?
Summer.76,
11.07.2023 16:34 Uhr
0
https://investors.caredx.com/news/news-details/2023/CareDxs-AlloSure-Lung-dd-cfDNA-Testing-Service-Receives-Medicare-Coverage-for-Lung-Transplant-Rejection-Monitoring/default.aspx
Summer.76,
10.05.2023 22:10 Uhr
0
https://www.businesswire.com/news/home/20230510005988/en/CareDx-Reports-First-Quarter-2023-Results
Summer.76,
05.04.2023 14:43 Uhr
0
CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation
https://finance.yahoo.com/news/caredx-miromatrix-announce-exclusive-partnership-105500224.html?guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAE0U4MUjtoO1w4LDWZ7q2mibjGxH2qVRJJEoUku1FhXU6lu2fK5W2Tp6tMBCqQaPK824V3vAtcayeZu0na8B4Na8X4tBRsB_E3EpWKI8lx5MMCrfaQ56mayqeQdzrhQlfghnMi_yUTdN4WDUnQnf5y_p1B8LpFO0AoEHwIgB1lDr
Summer.76,
27.02.2023 22:15 Uhr
0
https://www.businesswire.com/news/home/20230227005720/en/CareDx-Reports-Fourth-Quarter-and-Full-Year-2022-Results
Summer.76,
16.02.2023 13:24 Uhr
0
https://www.businesswire.com/news/home/20230216005360/en/CareDx-Showcases-Latest-Advancements-in-Cellular-Transplant-and-Therapy-Including-Specialized-Digital-Health-Solutions-at-the-2023-Tandem-Meetings
Summer.76,
09.01.2023 15:19 Uhr
0
https://www.businesswire.com/news/home/20230109005336/en/CareDx-Reports-Preliminary-Revenue-Results-for-Fourth-Quarter-and-Full-Year-2022
abeni,
06.12.2022 14:11 Uhr
0
CareDx Announces $50 Million Stock Repurchase Program
https://www.stocktitan.net/news/CDNA/care-dx-announces-50-million-stock-repurchase-0ojbl84wccp3.html?s=35
Summer.76,
11.11.2022 16:09 Uhr
0
https://www.businesswire.com/news/home/20221111005229/en/CareDx-Committed-to-Delivering-Clinical-Innovation-to-the-Transplant-Patient-and-Physician-Community
Summer.76,
03.11.2022 21:42 Uhr
0
CareDx GAAP EPS of -$0.06 beats by $0.33, revenue of $79.4M misses by $3.22M
https://seekingalpha.com/news/3901313-caredx-gaap-eps-of-0_06-beats-0_33-revenue-of-79_4m-misses-3_22m
• CareDx press release (NASDAQ:CDNA): Q3 GAAP EPS of -$0.06 beats by $0.33.
• Revenue of $79.4M (+5.0% Y/Y) misses by $3.22M.
• For the full year 2022, CareDx is revising our revenue expectations to be in the range of $320 million to $325 million due to lower Q3 revenue and a higher than anticipated shift in payer mix to commercial payors.
• Full year consensus revenue estimate is $327.79M.
Summer.76,
03.11.2022 21:07 Uhr
0
CareDx Reports Third Quarter 2022 Results
https://www.benzinga.com/pressreleases/22/11/b29555287/caredx-reports-third-quarter-2022-results
Summer.76,
01.11.2022 12:09 Uhr
0
https://www.businesswire.com/news/home/20221101005639/en/Independent-Longitudinal-Study-Finds-CareDx%E2%80%99s-AlloSure-Detects-Early-Signs-of-Rejection-in-Pediatric-Kidney-Transplant-Patients
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | Trading- und Aktien-Chat | ||
2 | XRP zu USD Hauptdiskussion | +10,94 % | |
3 | MicroStrategy | +1,69 % | |
4 | Palantir | +0,23 % | |
5 | BIOXCEL THERAPEUT DL-,001 Hauptdiskussion | +4,08 % | |
6 | PLUG POWER Hauptdiskussion | -0,54 % | |
7 | NVIDIA Hauptdiskussion | -0,12 % | |
8 | Polestar Automotive | ±0,00 % | |
9 | EVOTEC Hauptdiskussion | ±0,00 % | |
10 | CARBIOS Hauptdiskussion | ±0,00 % | Alle Diskussionen |
Aktien
|
Thema | ||
---|---|---|---|
1 | MicroStrategy | +1,69 % | |
2 | Palantir | +0,23 % | |
3 | PLUG POWER Hauptdiskussion | -0,54 % | |
4 | NVIDIA Hauptdiskussion | -0,12 % | |
5 | BIOXCEL THERAPEUT DL-,001 Hauptdiskussion | +4,08 % | |
6 | Polestar Automotive | ±0,00 % | |
7 | CARBIOS Hauptdiskussion | ±0,00 % | |
8 | Nio für normale Kommunikation | ±0,00 % | |
9 | EVOTEC Hauptdiskussion | ±0,00 % | |
10 | BASF Hauptdiskussion | ±0,00 % | Alle Diskussionen |